Cubist Pharmaceuticals Inc (CBST.OQ)

CBST.OQ on NASDAQ Stock Exchange Global Select Market

1:02pm EDT
Price Change (% chg)

$0.01 (+0.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for CBST.OQ


Cubist Pharmaceuticals, Inc. (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of therapies to treat serious medical conditions in acutely ill patients who are hospitalized or are being treated in other acute care settings. As of December 31, 2011, the Company had two marketed... (more)


Beta: 0.65
Market Cap (Mil.): $4,712.61
Shares Outstanding (Mil.): 75.31
Dividend: --
Yield (%): --


  CBST.OQ Industry Sector
P/E (TTM): 18,792.79 36.00 36.40
EPS (TTM): 0.00 -- --
ROI: 0.36 19.00 18.27
ROE: 0.66 19.78 19.15
Search Stocks

UPDATE 1-FDA approves Cubist drug to treat acute skin infections

June 20 - The U.S. Food and Drug Administration said on Friday it approved a new drug to treat acute bacterial skin infections made by Cubist Pharmaceuticals Inc.

20 Jun 2014

FDA panel says Cubist anti-infective shows efficacy, safety

March 31 - Cubist Pharmaceuticals Inc's anti-infective tedizolid for acute bacterial skin infections shows substantial evidence of safety and efficacy, an advisory panel to the U.S. Food and Drug Administration concluded on Monday.

31 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
Provider: S&P Capital IQ Factual Report
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks